Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Duffy antigen receptor for chemokines gene polymorphisms and malaria in Mangaluru, India.

Gai PP, van Loon W, Siegert K, Wedam J, Kulkarni SS, Rasalkar R, Boloor A, Kumar A, Jain A, Mahabala C, Baliga S, Devi R, Shenoy D, Gai P, Mockenhaupt FP.

Malar J. 2019 Sep 24;18(1):328. doi: 10.1186/s12936-019-2966-9.

2.

Characterization of Plasmodium vivax pvmdr1 Polymorphisms in Isolates from Mangaluru, India.

Tacoli C, Gai PP, Siegert K, Wedam J, Kulkarni SS, Rasalkar R, Boloor A, Jain A, Mahabala C, Baliga S, Shenoy D, Gai P, Devi R, Mockenhaupt FP.

Am J Trop Med Hyg. 2019 Aug;101(2):416-417. doi: 10.4269/ajtmh.19-0224.

PMID:
31218998
3.

Malaria Severity in Mangaluru City in the Southwestern Coastal Region of India.

Dayanand KK, Kishore P, Chandrashekar V, Achur RN, Ghosh SK, Kakkilaya SB, Kumari SN, Tiwari S, Boloor A, Devi R, Gowda DC.

Am J Trop Med Hyg. 2019 Feb;100(2):275-279. doi: 10.4269/ajtmh.18-0005.

PMID:
30734693
4.

Molecular Evidence for Plasmodium falciparum Resistance to Sulfadoxine-Pyrimethamine but Absence of K13 Mutations in Mangaluru, Southwestern India.

Wedam J, Tacoli C, Gai PP, Siegert K, Kulkarni SS, Rasalkar R, Boloor A, Jain A, Mahabala C, Baliga S, Shenoy D, Devi R, Gai P, Mockenhaupt FP.

Am J Trop Med Hyg. 2018 Dec;99(6):1508-1510. doi: 10.4269/ajtmh.18-0549.

PMID:
30398146
5.

Manifestation of malaria in Mangaluru, southern India.

Gai PP, Mockenhaupt FP, Siegert K, Wedam J, Boloor A, Kulkarni SS, Rasalkar R, Kumar A, Jain A, Mahabala C, Gai P, Baliga S, Devi R, Shenoy D.

Malar J. 2018 Aug 29;17(1):313. doi: 10.1186/s12936-018-2462-7.

6.

Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibitors.

Bennett MJ, Wu Y, Boloor A, Matuszkiewicz J, O'Connell SM, Shi L, Stansfield RK, Del Rosario JR, Veal JM, Hosfield DJ, Xu J, Kaldor SW, Stafford JA, Betancort JM.

Bioorg Med Chem Lett. 2018 Jun 1;28(10):1811-1816. doi: 10.1016/j.bmcl.2018.04.016. Epub 2018 Apr 10.

PMID:
29657099
7.

The role of fresh frozen plasma in reducing the volume of anti-snake venom in snakebite envenomation.

Holla SK, Rao HA, Shenoy D, Boloor A, Boyanagari M.

Trop Doct. 2018 Apr;48(2):89-93. doi: 10.1177/0049475518756083. Epub 2018 Feb 2.

PMID:
29393003
8.

Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate.

Keung W, Boloor A, Brown J, Kiryanov A, Gangloff A, Lawson JD, Skene R, Hoffman I, Atienza J, Kahana J, De Jong R, Farrell P, Balakrishna D, Halkowycz P.

Bioorg Med Chem Lett. 2017 Feb 15;27(4):1099-1104. doi: 10.1016/j.bmcl.2016.12.024. Epub 2016 Dec 20.

PMID:
28082036
9.

Study of Adverse Effect Profile of Parenteral Zoledronic Acid in Female Patients with Osteoporosis.

Kotian P, Boloor A, Sreenivasan S.

J Clin Diagn Res. 2016 Jan;10(1):OC04-6. doi: 10.7860/JCDR/2016/17061.7021. Epub 2016 Jan 1.

10.

Atypical Manifestations of Dengue Fever (DF) - Where Do We Stand Today?

Nimmagadda SS, Mahabala C, Boloor A, Raghuram PM, Nayak U A.

J Clin Diagn Res. 2014 Jan;8(1):71-3. doi: 10.7860/JCDR/2014/6885.3960. Epub 2013 Jan 12.

11.

Postmortem diagnosis of acute haemorrhagic pancreatitis.

Shetty BS, Boloor A, Menezes RG, Shetty M, Menon A, Nagesh KR, Pai MR, Mathai AM, Rastogi P, Kanchan T, Naik R, Salian PR, Jain V, George AT.

J Forensic Leg Med. 2010 Aug;17(6):316-20. doi: 10.1016/j.jflm.2010.04.013. Epub 2010 May 13.

PMID:
20650420
12.

Unusual presentation of multiple myeloma.

Shenoy K, Boloor A, Pai S, Suddharsan DS.

Indian J Cancer. 2010 Jul-Sep;47(3):347-8. doi: 10.4103/0019-509X.64709. No abstract available.

13.

Synthesis and antiviral activity of HCV NS3/4A peptidomimetic boronic acid inhibitors.

Boloor A, Hanway D, Joshi M, Winn DT, Mendez G, Walls M, Wei P, Qian F, Zhang X, Zhang Y, Hepperle ME, Li X, Campbell DA, Betancort JM.

Bioorg Med Chem Lett. 2009 Oct 1;19(19):5708-11. doi: 10.1016/j.bmcl.2009.08.017. Epub 2009 Aug 8.

PMID:
19713109
14.

Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor.

Harris PA, Boloor A, Cheung M, Kumar R, Crosby RM, Davis-Ward RG, Epperly AH, Hinkle KW, Hunter RN 3rd, Johnson JH, Knick VB, Laudeman CP, Luttrell DK, Mook RA, Nolte RT, Rudolph SK, Szewczyk JR, Truesdale AT, Veal JM, Wang L, Stafford JA.

J Med Chem. 2008 Aug 14;51(15):4632-40. doi: 10.1021/jm800566m. Epub 2008 Jul 12.

PMID:
18620382
15.

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.

Kumar R, Knick VB, Rudolph SK, Johnson JH, Crosby RM, Crouthamel MC, Hopper TM, Miller CG, Harrington LE, Onori JA, Mullin RJ, Gilmer TM, Truesdale AT, Epperly AH, Boloor A, Stafford JA, Luttrell DK, Cheung M.

Mol Cancer Ther. 2007 Jul;6(7):2012-21.

16.

Efficient and regioselective synthesis of 2-alkyl-2H-indazoles.

Cheung M, Boloor A, Stafford JA.

J Org Chem. 2003 May 16;68(10):4093-5.

PMID:
12737599

Supplemental Content

Loading ...
Support Center